

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.85951922 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.85951922 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.85951922 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.85951922 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.85951922 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.85951922 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.82865579 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.78471037 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.78471037 |
| 10 | response to peptidoglycan (GO:0032494) | 5.72913205 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.37279711 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 5.26972267 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.12203727 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 5.11424491 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.08579094 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 5.01687315 |
| 17 | detection of other organism (GO:0098543) | 4.85482856 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.81666560 |
| 19 | response to host immune response (GO:0052572) | 4.81666560 |
| 20 | detection of bacterium (GO:0016045) | 4.59015048 |
| 21 | granulocyte activation (GO:0036230) | 4.45704660 |
| 22 | microglial cell activation (GO:0001774) | 4.39590833 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.38895688 |
| 24 | response to host (GO:0075136) | 4.38895688 |
| 25 | response to host defenses (GO:0052200) | 4.38895688 |
| 26 | leukocyte aggregation (GO:0070486) | 4.35740872 |
| 27 | neutrophil activation (GO:0042119) | 4.34676822 |
| 28 | * respiratory burst (GO:0045730) | 4.30979947 |
| 29 | detection of external biotic stimulus (GO:0098581) | 4.28992865 |
| 30 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.25462955 |
| 31 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.13220861 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12056976 |
| 33 | positive regulation of mast cell degranulation (GO:0043306) | 4.10503253 |
| 34 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.10503253 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04495429 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95681755 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.95681755 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.94469920 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.93620755 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 3.92725745 |
| 41 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.91433912 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.85050747 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83815887 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.83394301 |
| 45 | macrophage activation (GO:0042116) | 3.82117951 |
| 46 | positive regulation of interferon-beta production (GO:0032728) | 3.81821244 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.79989261 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.79980059 |
| 49 | type I interferon signaling pathway (GO:0060337) | 3.78937185 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.78937185 |
| 51 | B cell mediated immunity (GO:0019724) | 3.78872194 |
| 52 | response to muramyl dipeptide (GO:0032495) | 3.78364847 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76075918 |
| 54 | response to type I interferon (GO:0034340) | 3.75874192 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.73533187 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.71129715 |
| 57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.67955851 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.66676563 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60090150 |
| 60 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.55065166 |
| 61 | superoxide anion generation (GO:0042554) | 3.53697021 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51393772 |
| 63 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.48955155 |
| 64 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.45571989 |
| 65 | regulation of mast cell activation (GO:0033003) | 3.43857624 |
| 66 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.43508205 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 3.42549337 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41852661 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40700948 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40236663 |
| 71 | regulation of chemokine biosynthetic process (GO:0045073) | 3.39204710 |
| 72 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39194658 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 3.39133586 |
| 74 | neutrophil mediated immunity (GO:0002446) | 3.37193535 |
| 75 | positive regulation of leukocyte degranulation (GO:0043302) | 3.36676507 |
| 76 | cellular extravasation (GO:0045123) | 3.33901780 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.31987433 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 3.31549351 |
| 79 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.31549351 |
| 80 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.30779086 |
| 81 | defense response to protozoan (GO:0042832) | 3.25428765 |
| 82 | leukocyte mediated cytotoxicity (GO:0001909) | 3.24754422 |
| 83 | regulation of antigen processing and presentation (GO:0002577) | 3.21264648 |
| 84 | detection of molecule of bacterial origin (GO:0032490) | 3.21078292 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18757832 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.18610994 |
| 87 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16727112 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 3.16468632 |
| 89 | response to interleukin-15 (GO:0070672) | 3.14864687 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14004097 |
| 91 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.13160941 |
| 92 | T-helper 1 type immune response (GO:0042088) | 3.10339970 |
| 93 | I-kappaB phosphorylation (GO:0007252) | 3.10020619 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 3.07200636 |
| 95 | positive regulation of heat generation (GO:0031652) | 3.05393961 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04030350 |
| 97 | neutrophil chemotaxis (GO:0030593) | 3.02732853 |
| 98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.01248675 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 3.01239317 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.99644989 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98675952 |
| 102 | myeloid leukocyte activation (GO:0002274) | 2.97507708 |
| 103 | cellular response to interferon-beta (GO:0035458) | 2.96961559 |
| 104 | positive regulation of type 2 immune response (GO:0002830) | 2.96939606 |
| 105 | regulation of interferon-beta production (GO:0032648) | 2.96425076 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.95437368 |
| 107 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95276504 |
| 108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95188954 |
| 109 | negative regulation of mast cell activation (GO:0033004) | 2.94980799 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 2.94735683 |
| 111 | neutrophil migration (GO:1990266) | 2.93885319 |
| 112 | cellular response to zinc ion (GO:0071294) | 2.93652168 |
| 113 | regulation of B cell differentiation (GO:0045577) | 2.93337731 |
| 114 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92923242 |
| 115 | response to interferon-alpha (GO:0035455) | 2.92850635 |
| 116 | positive regulation of chemokine production (GO:0032722) | 2.92809403 |
| 117 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.92383525 |
| 118 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92162326 |
| 119 | regulation of fever generation (GO:0031620) | 2.88844475 |
| 120 | T cell migration (GO:0072678) | 2.88232625 |
| 121 | lymphocyte mediated immunity (GO:0002449) | 2.85594751 |
| 122 | negative regulation of interleukin-6 production (GO:0032715) | 2.85409751 |
| 123 | negative regulation of innate immune response (GO:0045824) | 2.85373156 |
| 124 | cellular response to interleukin-15 (GO:0071350) | 2.84372502 |
| 125 | response to protozoan (GO:0001562) | 2.82205335 |
| 126 | regulation of regulated secretory pathway (GO:1903305) | 2.81819968 |
| 127 | negative regulation of viral genome replication (GO:0045071) | 2.81445030 |
| 128 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80665164 |
| 129 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.79736088 |
| 130 | cytokine secretion (GO:0050663) | 2.77669855 |
| 131 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.77669386 |
| 132 | germinal center formation (GO:0002467) | 2.77554398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.09809170 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.79129175 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.45781049 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.51633099 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.15418666 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.08360660 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.05352658 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67490096 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46350909 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.28490120 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21005958 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.07011781 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.04402655 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96575686 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81821826 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.79422704 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66867104 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52864836 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43292314 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.41200496 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37115158 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.33912342 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97048940 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95694252 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92054920 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90977086 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84520607 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83870892 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82662368 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.81663363 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78559002 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.77849406 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72100997 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65121926 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65047007 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64160351 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63516166 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62831964 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59029519 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58971219 |
| 41 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57681062 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.56721612 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56250903 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54343789 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51562720 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50978653 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39323381 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37040617 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36954148 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.34995012 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34840566 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32576306 |
| 53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30363819 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29246025 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29112152 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29004312 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27008717 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22757439 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22379655 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21054140 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20412198 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20298470 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17550334 |
| 64 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15283026 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08290312 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.08210683 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06221440 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03324664 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.03257165 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01667277 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99318780 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97998909 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96705389 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96539377 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95006114 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94586411 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94009488 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91120771 |
| 79 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.90255002 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89850473 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89359283 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88773395 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88209486 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87221691 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85460234 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85228488 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81807567 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81314543 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81049256 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80465258 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80153350 |
| 92 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79646576 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78223333 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78145114 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77578765 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76407047 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74227259 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73789540 |
| 99 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.69075972 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68638215 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.67105158 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66074287 |
| 103 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.65307101 |
| 104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.61320230 |
| 105 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60496068 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.60065507 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.59264373 |
| 108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59165162 |
| 109 | P300_27268052_Chip-Seq_Bcells_Human | 0.59118991 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.58815876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.59791612 |
| 2 | MP0003303_peritoneal_inflammation | 4.25426455 |
| 3 | MP0003436_decreased_susceptibility_to | 3.95200508 |
| 4 | MP0009785_altered_susceptibility_to | 3.75073430 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.24405963 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.13185751 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.12978085 |
| 8 | MP0006082_CNS_inflammation | 3.11508974 |
| 9 | MP0005025_abnormal_response_to | 2.97795713 |
| 10 | * MP0001790_abnormal_immune_system | 2.89913226 |
| 11 | * MP0005387_immune_system_phenotype | 2.89913226 |
| 12 | MP0003724_increased_susceptibility_to | 2.84249760 |
| 13 | MP0000685_abnormal_immune_system | 2.82111624 |
| 14 | MP0001800_abnormal_humoral_immune | 2.80864817 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.80236551 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.72436454 |
| 17 | * MP0002723_abnormal_immune_serum | 2.55491423 |
| 18 | MP0004510_myositis | 2.52284408 |
| 19 | MP0005671_abnormal_response_to | 2.48863016 |
| 20 | * MP0001819_abnormal_immune_cell | 2.35241045 |
| 21 | MP0009278_abnormal_bone_marrow | 2.35227598 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.31974339 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.22969210 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.12829478 |
| 25 | MP0004947_skin_inflammation | 1.99010220 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.98695676 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.98065353 |
| 28 | * MP0001845_abnormal_inflammatory_respons | 1.93179903 |
| 29 | * MP0002405_respiratory_system_inflammati | 1.85720725 |
| 30 | MP0001853_heart_inflammation | 1.82985632 |
| 31 | MP0003075_altered_response_to | 1.80789011 |
| 32 | MP0000343_altered_response_to | 1.80228135 |
| 33 | MP0009764_decreased_sensitivity_to | 1.78760113 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.73819604 |
| 35 | * MP0000716_abnormal_immune_system | 1.69578327 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.69484765 |
| 37 | * MP0008469_abnormal_protein_level | 1.69239011 |
| 38 | MP0009840_abnormal_foam_cell | 1.69030290 |
| 39 | MP0003448_altered_tumor_morphology | 1.63592408 |
| 40 | MP0002006_tumorigenesis | 1.60895682 |
| 41 | * MP0002398_abnormal_bone_marrow | 1.59110084 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.57336066 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.51615405 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.50927032 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.50927032 |
| 46 | * MP0000689_abnormal_spleen_morphology | 1.43171479 |
| 47 | * MP0002429_abnormal_blood_cell | 1.37659581 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.34836423 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.34727327 |
| 50 | MP0000858_altered_metastatic_potential | 1.33869237 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.33465365 |
| 52 | MP0005166_decreased_susceptibility_to | 1.31317451 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.30699655 |
| 54 | MP0005310_abnormal_salivary_gland | 1.29911664 |
| 55 | MP0002132_abnormal_respiratory_system | 1.29651298 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.26319186 |
| 57 | * MP0002722_abnormal_immune_system | 1.23205712 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.22679813 |
| 59 | MP0010307_abnormal_tumor_latency | 1.19270290 |
| 60 | MP0000604_amyloidosis | 1.18132809 |
| 61 | MP0008004_abnormal_stomach_pH | 1.16963179 |
| 62 | MP0005164_abnormal_response_to | 1.13825033 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.06869394 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.04248162 |
| 65 | MP0002933_joint_inflammation | 1.03048457 |
| 66 | MP0001873_stomach_inflammation | 1.00394051 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.00366974 |
| 68 | MP0005390_skeleton_phenotype | 0.99780873 |
| 69 | MP0003690_abnormal_glial_cell | 0.99576516 |
| 70 | MP0001851_eye_inflammation | 0.99244021 |
| 71 | MP0004858_abnormal_nervous_system | 0.96857974 |
| 72 | MP0009763_increased_sensitivity_to | 0.96569984 |
| 73 | MP0003828_pulmonary_edema | 0.96283119 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.95406725 |
| 75 | MP0004381_abnormal_hair_follicle | 0.89126754 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.88374635 |
| 77 | MP0008260_abnormal_autophagy | 0.88108896 |
| 78 | MP0005023_abnormal_wound_healing | 0.86379872 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 0.85866432 |
| 80 | MP0003091_abnormal_cell_migration | 0.84695540 |
| 81 | MP0003186_abnormal_redox_activity | 0.82156826 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.80455001 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.80082402 |
| 84 | MP0000249_abnormal_blood_vessel | 0.78842711 |
| 85 | MP0004883_abnormal_blood_vessel | 0.77606709 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.77477595 |
| 87 | MP0000490_abnormal_crypts_of | 0.75763969 |
| 88 | MP0008874_decreased_physiological_sensi | 0.71312383 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.68425863 |
| 90 | MP0000920_abnormal_myelination | 0.66849631 |
| 91 | MP0006054_spinal_hemorrhage | 0.66323311 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.66083185 |
| 93 | MP0003763_abnormal_thymus_physiology | 0.65724226 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.65264695 |
| 95 | MP0001663_abnormal_digestive_system | 0.62809294 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.61889448 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.61349757 |
| 98 | MP0002254_reproductive_system_inflammat | 0.61114462 |
| 99 | MP0000371_diluted_coat_color | 0.59882984 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.59697746 |
| 101 | MP0003329_amyloid_beta_deposits | 0.59152472 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.58760869 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.58268570 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.58041134 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57841314 |
| 106 | * MP0003795_abnormal_bone_structure | 0.57656067 |
| 107 | MP0005451_abnormal_body_composition | 0.56748857 |
| 108 | MP0000609_abnormal_liver_physiology | 0.55386874 |
| 109 | MP0003866_abnormal_defecation | 0.55380893 |
| 110 | MP0003045_fibrosis | 0.55117535 |
| 111 | MP0008873_increased_physiological_sensi | 0.52449052 |
| 112 | * MP0000703_abnormal_thymus_morphology | 0.51031913 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.49681497 |
| 114 | MP0005381_digestive/alimentary_phenotyp | 0.46256887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.80147123 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.18716928 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.11251419 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.41421018 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.26395035 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.05699606 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.56997475 |
| 8 | Obstructive lung disease (HP:0006536) | 4.47220201 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.47220201 |
| 10 | Recurrent skin infections (HP:0001581) | 4.25785859 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.21665753 |
| 12 | Gingivitis (HP:0000230) | 4.20364702 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.17002707 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.12520737 |
| 15 | Myositis (HP:0100614) | 3.95565829 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.90708363 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.84803556 |
| 18 | Cellulitis (HP:0100658) | 3.83846452 |
| 19 | Stomatitis (HP:0010280) | 3.83495843 |
| 20 | Vasculitis (HP:0002633) | 3.80348187 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.77977380 |
| 22 | Orchitis (HP:0100796) | 3.68046070 |
| 23 | Recurrent viral infections (HP:0004429) | 3.55723626 |
| 24 | Keratoconjunctivitis (HP:0001096) | 3.43521562 |
| 25 | Glomerulonephritis (HP:0000099) | 3.40632138 |
| 26 | Encephalitis (HP:0002383) | 3.39520377 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.34385893 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.30848334 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.30848334 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.30848334 |
| 31 | Hematochezia (HP:0002573) | 3.26368467 |
| 32 | Chronic otitis media (HP:0000389) | 3.24048099 |
| 33 | Meningitis (HP:0001287) | 3.20526976 |
| 34 | Optic neuritis (HP:0100653) | 3.19537168 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 3.19537168 |
| 36 | Urticaria (HP:0001025) | 3.17859387 |
| 37 | Pustule (HP:0200039) | 3.15007635 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.93356170 |
| 39 | Chest pain (HP:0100749) | 2.89751736 |
| 40 | Periodontitis (HP:0000704) | 2.89530538 |
| 41 | T lymphocytopenia (HP:0005403) | 2.86906329 |
| 42 | Colitis (HP:0002583) | 2.86537632 |
| 43 | Axonal loss (HP:0003447) | 2.85414147 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.84911033 |
| 45 | Episodic fever (HP:0001954) | 2.84381896 |
| 46 | Basal ganglia calcification (HP:0002135) | 2.84190976 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.81870968 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.81103684 |
| 49 | Osteomyelitis (HP:0002754) | 2.80962778 |
| 50 | Disinhibition (HP:0000734) | 2.75446682 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.72599638 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.70661619 |
| 53 | Nephritis (HP:0000123) | 2.68068567 |
| 54 | Anorexia (HP:0002039) | 2.67078874 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.66509230 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.64034025 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.64034025 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.61856698 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.60836598 |
| 60 | Thick nail (HP:0001805) | 2.58528604 |
| 61 | Pulmonary embolism (HP:0002204) | 2.57710733 |
| 62 | Loss of speech (HP:0002371) | 2.56798238 |
| 63 | Increased IgM level (HP:0003496) | 2.55441804 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.55149097 |
| 65 | Epistaxis (HP:0000421) | 2.52145253 |
| 66 | Peritonitis (HP:0002586) | 2.51528339 |
| 67 | Gangrene (HP:0100758) | 2.49313343 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 2.48825436 |
| 69 | Prostate neoplasm (HP:0100787) | 2.47804177 |
| 70 | Abnormality of the nasal mucosa (HP:0000433) | 2.46246350 |
| 71 | Emphysema (HP:0002097) | 2.46078602 |
| 72 | Purpura (HP:0000979) | 2.46062937 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.45584877 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.45094170 |
| 75 | Hemoptysis (HP:0002105) | 2.45083641 |
| 76 | Hypochromic anemia (HP:0001931) | 2.40779594 |
| 77 | Nasal polyposis (HP:0100582) | 2.38166847 |
| 78 | Tetraparesis (HP:0002273) | 2.38040246 |
| 79 | Agnosia (HP:0010524) | 2.36159952 |
| 80 | Abnormality of complement system (HP:0005339) | 2.35632453 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.34824303 |
| 82 | Restrictive lung disease (HP:0002091) | 2.33842853 |
| 83 | Leukocytosis (HP:0001974) | 2.32952071 |
| 84 | Gingival bleeding (HP:0000225) | 2.27433820 |
| 85 | Abnormality of T cells (HP:0002843) | 2.23536506 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.22773634 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22681348 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.22681348 |
| 89 | Myocardial infarction (HP:0001658) | 2.21035065 |
| 90 | Skin ulcer (HP:0200042) | 2.20878993 |
| 91 | Arterial thrombosis (HP:0004420) | 2.19349914 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.15573722 |
| 93 | IgM deficiency (HP:0002850) | 2.14714542 |
| 94 | Granulocytopenia (HP:0001913) | 2.14095999 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13750443 |
| 96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10821723 |
| 97 | Lymphopenia (HP:0001888) | 2.10392322 |
| 98 | Glomerulopathy (HP:0100820) | 2.10370139 |
| 99 | Vertigo (HP:0002321) | 2.09541886 |
| 100 | Polyneuropathy (HP:0001271) | 2.09515194 |
| 101 | Abnormality of the endocardium (HP:0004306) | 2.08857145 |
| 102 | Petechiae (HP:0000967) | 2.07456390 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07256973 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07256973 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07256973 |
| 106 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06577387 |
| 107 | Osteolytic defects of the hand bones (HP:0009699) | 2.06577387 |
| 108 | Panhypogammaglobulinemia (HP:0003139) | 2.06444099 |
| 109 | Sepsis (HP:0100806) | 2.06111003 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.03561285 |
| 111 | Premature loss of primary teeth (HP:0006323) | 2.02866213 |
| 112 | Acne (HP:0001061) | 2.01193091 |
| 113 | Agammaglobulinemia (HP:0004432) | 2.00963321 |
| 114 | Keratoconjunctivitis sicca (HP:0001097) | 2.00636405 |
| 115 | Amyloidosis (HP:0011034) | 1.99722383 |
| 116 | Mutism (HP:0002300) | 1.98779866 |
| 117 | Poor head control (HP:0002421) | 1.97536308 |
| 118 | Pathologic fracture (HP:0002756) | 1.96249312 |
| 119 | Gastrointestinal infarctions (HP:0005244) | 1.95631676 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.94076255 |
| 121 | Abnormality of the pleura (HP:0002103) | 1.93169201 |
| 122 | Arthralgia (HP:0002829) | 1.92557613 |
| 123 | Malnutrition (HP:0004395) | 1.91864351 |
| 124 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91848804 |
| 125 | Increased IgE level (HP:0003212) | 1.91633060 |
| 126 | Microcytic anemia (HP:0001935) | 1.91589096 |
| 127 | Complement deficiency (HP:0004431) | 1.89497415 |
| 128 | Keratitis (HP:0000491) | 1.89085139 |
| 129 | Eosinophilia (HP:0001880) | 1.88125741 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88037424 |
| 131 | Increased serum ferritin (HP:0003281) | 1.87484099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.43173692 |
| 2 | BLK | 3.86601253 |
| 3 | MAP3K14 | 3.66811326 |
| 4 | MAP4K1 | 3.64558628 |
| 5 | IRAK4 | 3.59866193 |
| 6 | TYK2 | 3.50050565 |
| 7 | TBK1 | 3.46334825 |
| 8 | ERN1 | 3.03581688 |
| 9 | IRAK3 | 2.88738064 |
| 10 | IKBKE | 2.58562250 |
| 11 | KIT | 2.23413064 |
| 12 | PRPF4B | 2.18101793 |
| 13 | IKBKB | 2.06183176 |
| 14 | CSF1R | 2.05553996 |
| 15 | JAK1 | 2.02868677 |
| 16 | FGR | 2.01002828 |
| 17 | TAOK1 | 1.95967198 |
| 18 | TNK2 | 1.95909871 |
| 19 | TGFBR2 | 1.94729513 |
| 20 | JAK3 | 1.93595298 |
| 21 | PBK | 1.81459133 |
| 22 | STK10 | 1.80108754 |
| 23 | MAP3K13 | 1.77294483 |
| 24 | * CSK | 1.63839377 |
| 25 | EPHB1 | 1.56110602 |
| 26 | ZAP70 | 1.54294989 |
| 27 | SYK | 1.51237337 |
| 28 | BTK | 1.47718053 |
| 29 | FES | 1.41744895 |
| 30 | MATK | 1.38807578 |
| 31 | TAOK2 | 1.36999139 |
| 32 | TXK | 1.30395132 |
| 33 | CLK1 | 1.27349633 |
| 34 | * HCK | 1.26926524 |
| 35 | SIK3 | 1.24355786 |
| 36 | RPS6KA4 | 1.20372631 |
| 37 | TEC | 1.16765496 |
| 38 | * LYN | 1.16630411 |
| 39 | CHUK | 1.16370036 |
| 40 | LCK | 1.08020786 |
| 41 | GRK6 | 1.05815300 |
| 42 | JAK2 | 1.05208592 |
| 43 | PIM1 | 1.02599253 |
| 44 | IRAK1 | 1.01621777 |
| 45 | FGFR4 | 1.00751206 |
| 46 | MAP3K10 | 0.99879414 |
| 47 | MAP2K3 | 0.98471915 |
| 48 | IRAK2 | 0.97606346 |
| 49 | MARK3 | 0.95754025 |
| 50 | CDC42BPA | 0.94119533 |
| 51 | LRRK2 | 0.93721241 |
| 52 | FGFR3 | 0.90307189 |
| 53 | RIPK1 | 0.89037308 |
| 54 | MARK2 | 0.85557650 |
| 55 | PIM2 | 0.85014731 |
| 56 | PTK6 | 0.78039658 |
| 57 | MAP3K11 | 0.77556194 |
| 58 | MST4 | 0.76279275 |
| 59 | GRK7 | 0.76056342 |
| 60 | BMX | 0.74432956 |
| 61 | EGFR | 0.72645556 |
| 62 | STK4 | 0.71042804 |
| 63 | PRKD2 | 0.69948497 |
| 64 | TAOK3 | 0.68987980 |
| 65 | MAP3K6 | 0.67129312 |
| 66 | CAMK1D | 0.66168930 |
| 67 | MOS | 0.65421060 |
| 68 | MAP3K5 | 0.64926849 |
| 69 | ABL1 | 0.63105846 |
| 70 | CDK19 | 0.63012483 |
| 71 | TTN | 0.62777710 |
| 72 | PRKCD | 0.62591068 |
| 73 | PAK4 | 0.61601461 |
| 74 | NEK9 | 0.60096373 |
| 75 | TRPM7 | 0.59699256 |
| 76 | ITK | 0.57316065 |
| 77 | SIK2 | 0.56574492 |
| 78 | YES1 | 0.56405389 |
| 79 | EIF2AK2 | 0.55730505 |
| 80 | TRIB3 | 0.55528201 |
| 81 | MAPK12 | 0.53414442 |
| 82 | CAMKK2 | 0.53274422 |
| 83 | MAP3K3 | 0.52832488 |
| 84 | DAPK2 | 0.52737830 |
| 85 | KSR2 | 0.52476003 |
| 86 | BMPR2 | 0.51407828 |
| 87 | MAPK7 | 0.51282288 |
| 88 | ALK | 0.49664216 |
| 89 | TESK1 | 0.49570099 |
| 90 | ABL2 | 0.49155804 |
| 91 | DYRK1B | 0.48489549 |
| 92 | MAP3K2 | 0.47854216 |
| 93 | PRKG2 | 0.46102339 |
| 94 | PDK1 | 0.45893366 |
| 95 | CDK12 | 0.45672505 |
| 96 | ARAF | 0.45072638 |
| 97 | MAP2K6 | 0.45003242 |
| 98 | MAPKAPK2 | 0.44344184 |
| 99 | KDR | 0.44097420 |
| 100 | MAP2K4 | 0.43869313 |
| 101 | PTK2B | 0.43778427 |
| 102 | NME2 | 0.43375368 |
| 103 | HIPK2 | 0.42725326 |
| 104 | SGK3 | 0.42714838 |
| 105 | STK11 | 0.41724179 |
| 106 | PIK3CG | 0.41185343 |
| 107 | MAP3K8 | 0.41031906 |
| 108 | RPS6KA6 | 0.40076527 |
| 109 | STK3 | 0.39835630 |
| 110 | SMG1 | 0.39608422 |
| 111 | PDPK1 | 0.39475449 |
| 112 | MAP3K1 | 0.39283734 |
| 113 | STK24 | 0.39159603 |
| 114 | PKN2 | 0.37324497 |
| 115 | KSR1 | 0.35636306 |
| 116 | SIK1 | 0.34710726 |
| 117 | MAP3K7 | 0.34343590 |
| 118 | ACVR1B | 0.33453082 |
| 119 | * FYN | 0.33011518 |
| 120 | PRKCQ | 0.32566951 |
| 121 | MAPK4 | 0.31001099 |
| 122 | RET | 0.29578865 |
| 123 | DDR2 | 0.29549249 |
| 124 | MAP3K9 | 0.29369867 |
| 125 | RPS6KC1 | 0.29247458 |
| 126 | RPS6KL1 | 0.29247458 |
| 127 | EPHA3 | 0.29163637 |
| 128 | FLT3 | 0.25479181 |
| 129 | TESK2 | 0.23745820 |
| 130 | ERBB3 | 0.23690002 |
| 131 | * INSR | 0.21055495 |
| 132 | MST1R | 0.20631247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.71618064 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.68168853 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.92207601 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.69840954 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.65200118 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.47425495 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.43560986 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31383506 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.30203209 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.29978543 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27685719 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.22041702 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18075745 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.12248316 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.03561365 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.93981277 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.88478482 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86954673 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79074440 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.78918916 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.77328484 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.73602667 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.69888005 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.69366669 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67654191 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66591026 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66476509 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66363970 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66262101 |
| 30 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63774410 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57780115 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57525553 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.55783681 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54630385 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45928020 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.45262139 |
| 37 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43016096 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.35994726 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28821093 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28142997 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23931947 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.16535459 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15880919 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15720595 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15133863 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.14359506 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09393316 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04315858 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.93861596 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90214708 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86878828 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85704685 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85034959 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84409542 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83904289 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82681361 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78959340 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78463593 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.77225520 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77164981 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73385774 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72487157 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.72373623 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70383932 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69945193 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68727016 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62337910 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54398809 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54349866 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53437149 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50180692 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49565997 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47439530 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47416498 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47392722 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46727330 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46550625 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46147899 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46111683 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45957695 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.45001139 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42848449 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41478660 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.40091573 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37811380 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36790343 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.36561661 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.35246673 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34608085 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33909926 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32764142 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31897143 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29575103 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28028844 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27747557 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27190271 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26128842 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24765429 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23876424 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23033669 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22950749 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22124651 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20782434 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19439564 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18069159 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17735055 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16945345 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15376425 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15365565 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.13619298 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13591419 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12125226 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11861908 |

